Prevalence of Hepatitis E During Follow-up Liver and Kidney Transplant Patients in Guadeloupe, French West Indies | MicrobiomeTrials← Back to trialsNCT07729202
Prevalence of Hepatitis E During Follow-up Liver and Kidney Transplant Patients in Guadeloupe, French West Indies
CompletedNAINTERVENTIONAL
Trial Details
Start: 2019-03-22Est. Completion: 2019-05-05
Enrollment target: 95 participants Locations- Centre Hospitalier Universitaire de la Guadeloupe, Les Abymes, Guadeloupe, Guadeloupe
Other microbiome trials you might be interested in
Hepatitis E
This study will assess the safety, tolerability and pharmacokinetics (PK) of AT-587 in healthy subjects
Edegem, BelgiumEst. completion Dec 2026
Solid TumorsHematologic Malignancies
The purpose of this study is to evaluate the long-term safety and efficacy of pembrolizumab (MK-3475) in participants fr…
Tucson, United StatesEst. completion Aug 4, 2043